Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.

Lexaria Bioscience ( ($LEXX) ) just unveiled an update. Lexaria reported that its Phase 1b, 12‑week chronic study GLP-1-H24-4 in Australia met its ...

GLP-1 drugs are a class of medication used to treat type 2 diabetes and obesity. While they are generally safe to use, they can cause side effects, such as nausea, vomiting, and diarrhea. Starting on ...

Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...

GLP-1 drugs like Ozempic and Wegovy have rapidly moved from niche diabetes treatments to blockbuster weight loss injections, reshaping how doctors and patients think about obesity. As prescriptions ...

As use of GLP-1 receptor agonists (RAs) continues to rise exponentially, awareness of its most common side effects, such as nausea and vomiting, is growing. But the drugs come with some lesser-known ...

(NEXSTAR) – Patients using Ozempic and other GLP-1 drugs are reporting a complication not listed among the drug’s most common side effects. (We’re not talking about “Ozempic babies,” but that’s also a ...

Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to manage blood sugar and support weight loss, these medications are currently being studied ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research. Reading time 2 minutes Every drug has its risks, no ...